Toll-like receptors (TLRs) are considered as the most crucial immunological mediators in human [7, 8], and inhibiting TLR-mediated NF-kappa-B (NF-κB) could alleviate RA [9]. This evidence concerns the gene NFKB1 and rheumatoid arthritis.